Vicker N - Search Results

1

The design of novel 17beta-hydroxysteroid dehydrogenase type 3 inhibitors.

Vicker N, Sharland CM, Heaton WB, Gonzalez AM, Bailey HV, Smith A, Springall JS, Day JM, Tutill HJ, Reed MJ, Purohit A, Potter BV. Vicker N, et al. Mol Cell Endocrinol. 2009 Mar 25;301(1-2):259-65. doi: 10.1016/j.mce.2008.08.005. Epub 2008 Aug 15. Mol Cell Endocrinol. 2009. PMID: 18775469

2

The regulation and inhibition of 17beta-hydroxysteroid dehydrogenase in breast cancer.

Purohit A, Tutill HJ, Day JM, Chander SK, Lawrence HR, Allan GM, Fischer DS, Vicker N, Newman SP, Potter BV, Reed MJ. Purohit A, et al. Among authors: vicker n. Mol Cell Endocrinol. 2006 Mar 27;248(1-2):199-203. doi: 10.1016/j.mce.2005.12.003. Epub 2006 Jan 18. Mol Cell Endocrinol. 2006. PMID: 16414180

3

Novel 18beta-glycyrrhetinic acid analogues as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenases.

Su X, Lawrence H, Ganeshapillai D, Cruttenden A, Purohit A, Reed MJ, Vicker N, Potter BV. Su X, et al. Among authors: vicker n. Bioorg Med Chem. 2004 Aug 15;12(16):4439-57. doi: 10.1016/j.bmc.2004.06.008. Bioorg Med Chem. 2004. PMID: 15265495

4

Novel and potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors.

Lawrence HR, Vicker N, Allan GM, Smith A, Mahon MF, Tutill HJ, Purohit A, Reed MJ, Potter BV. Lawrence HR, et al. Among authors: vicker n. J Med Chem. 2005 Apr 21;48(8):2759-62. doi: 10.1021/jm049045r. J Med Chem. 2005. PMID: 15828812

5

E-ring modified steroids as novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

Fischer DS, Allan GM, Bubert C, Vicker N, Smith A, Tutill HJ, Purohit A, Wood L, Packham G, Mahon MF, Reed MJ, Potter BV. Fischer DS, et al. Among authors: vicker n. J Med Chem. 2005 Sep 8;48(18):5749-70. doi: 10.1021/jm050348a. J Med Chem. 2005. PMID: 16134943

6

Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.

Su X, Vicker N, Ganeshapillai D, Smith A, Purohit A, Reed MJ, Potter BV. Su X, et al. Among authors: vicker n. Mol Cell Endocrinol. 2006 Mar 27;248(1-2):214-7. doi: 10.1016/j.mce.2005.10.022. Epub 2005 Dec 1. Mol Cell Endocrinol. 2006. PMID: 16325333

7

Novel, potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

Allan GM, Bubert C, Vicker N, Smith A, Tutill HJ, Purohit A, Reed MJ, Potter BV. Allan GM, et al. Among authors: vicker n. Mol Cell Endocrinol. 2006 Mar 27;248(1-2):204-7. doi: 10.1016/j.mce.2005.10.021. Epub 2005 Dec 7. Mol Cell Endocrinol. 2006. PMID: 16337736

8

Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

Allan GM, Lawrence HR, Cornet J, Bubert C, Fischer DS, Vicker N, Smith A, Tutill HJ, Purohit A, Day JM, Mahon MF, Reed MJ, Potter BV. Allan GM, et al. Among authors: vicker n. J Med Chem. 2006 Feb 23;49(4):1325-45. doi: 10.1021/jm050830t. J Med Chem. 2006. PMID: 16480268

9

17Beta-hydroxysteroid dehydrogenase Type 1 and Type 2: association between mRNA expression and activity in cell lines.

Day JM, Tutill HJ, Newman SP, Purohit A, Lawrence HR, Vicker N, Potter BV, Reed MJ. Day JM, et al. Among authors: vicker n. Mol Cell Endocrinol. 2006 Mar 27;248(1-2):246-9. doi: 10.1016/j.mce.2006.01.011. Epub 2006 Feb 21. Mol Cell Endocrinol. 2006. PMID: 16490301

10

Focused libraries of 16-substituted estrone derivatives and modified e-ring steroids: inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

Vicker N, Lawrence HR, Allan GM, Bubert C, Smith A, Tutill HJ, Purohit A, Day JM, Mahon MF, Reed MJ, Potter BV. Vicker N, et al. ChemMedChem. 2006 Apr;1(4):464-81. doi: 10.1002/cmdc.200500087. ChemMedChem. 2006. PMID: 16892382

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters